Conference Schedule
Day1: November 12, 2018
Keynote Forum
Gerald C Hsu
Eclaire MD Foundation, USA
Title: Differences between fasting plasma glucose and postprandial plasma glucose
09:15-10:00
Biography
Gerald C Hsu has received an honorable PhD in Mathematics and majored in Engineering at MIT. He has attended different universities over 17 years and studied seven academic disciplines. First, he studied six Metabolic Diseases and Food Nutrition during 2010-2013, and then conducted research during 2014-2018. His approach is math-physics and quantitative medicine based on mathematics, physics, engineering modeling; signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.
Abstract
Shunlin Ren
Virginia Commonwealth University, USA
Title: Novel oxysterol sulfates alleviate injured-liver function and decrease mortality in LPS-induced mouse model
10:00-10:45
Biography
Shunlin Ren, Professor of Medicine and Research Career Scientist, received his Medical Degree from Shanghai First Medical College, and his PhD degree from Virginia Commonwealth University. He is a Principal Investigator. His research has been supported by NIH R01 and VA Merit Review grants, Research Career Scientist Award, American Liver Scholar Award, and Durect Corporation Research Agreement. He has published more than 50 papers in reputed journals and 55 US and World patents and patent application. He is serving as an Editorial Board Member of repute. His research has focused on the role of oxysterols and oxysterol sulfation in lipid metabolism, inflammatory responses and cell proliferation.
Abstract
Hani Oweira
Hirslanden Hospital Group, Switzerland
Title: Surgery of the liver and intraoperative interventional therapies what is possible today?
11:15 -12:00
Biography
Hani Oweira is a Visceral Surgeon working in the Hirslanden Private Hospital Group in Zurich and Cham in Switzerland. He was trained in Charite Berlin and the University Hospital in Heidelberg in Germany. His research is focused on the predictive markers for liver dysfunction after liver surgery and transplantation.
Abstract
Tracks
- Kidney and pancreas graft surgical re-innervation in clinics
- Blood rheology in people with diabetic foot ulcers: Polish insight on treatment of diabetic foot ulcers with physical medicine modalities
- Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis C virus cirrhosis
- Hepatic Abscess: Retrospective and Multicentric Study of 124 Observations to the University Hospital of Conakry
- Kidney and pancreas graft surgical re-innervation.
- Further developments of the energetic feedback for automated treatment of the severe acute glucose metabolism disorder monitoring
- Intrahepatic pseudoaneurysm following thoracoabdominal bomb blast injury: Reporting of surgical and endovascular management of a complex case
- Position and controversy with beta-blockers in cirrhosis in 2018
- Hepatitis B and Hepatology
Location: Carnot
Shunlin Ren
Virginia Commonwealth University, USA
Chair
Hani Oweira
Hirslanden Hospital Group, Switzerland
Co Chair
Dimitri Mikhalski
KUL,PFU,USSA, Belgium
Title: Kidney and pancreas graft surgical re-innervation in clinics
12:00-12:25
Biography
Dimitri Mikhalski currently working as a director of the transplantation department Hospital Erasme. He has completed his diploma in June 1998 at Katholieke Universiteit Leuven (KUL) Leuven, Belgium and Masters degree in People Friendship University (PFU) – Moscou, USSA. His research interest includes Full member Council of Organ Transplantation of Belgium and Consultant-Adviser Department "Conservation of the human organs "Superior Council of Health Care Belgium.
Abstract
Location: Carnot
Grzegorz Onik
Medical University of Silesia, Poland
Title: Blood rheology in people with diabetic foot ulcers: Polish insight on treatment of diabetic foot ulcers with physical medicine modalities
12:25-12:50
Biography
Grzegorz Onik has been graduated from Medical University of Silesia in Katowice as physiotherapist. Currently he works as a lecturer at Medical University of Silesia in Katowice in Department of Physical Medicine. He is member of Polish Society of Cryotherapy (Board Member) and Polish Society of Gastroenterological Rehabilitation.
Abstract
Location: Carnot
Tarek E Korah
Menoufiya University, Egypt
Title: Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis C virus cirrhosis
13:50-14:15
Biography
Professor Tarek E. Korah, has completed his MD at the age of 37 years from Faculty of Medicine, Menoufiya University, and then he did postdoctoral studies. He was the head of Gastroenterology and Hepatology Unit, in the same University during 2012 till 2015. He has published more than 30 papers in reputed medical journals, has been serving as a reviewer in some of these journals.
Abstract
Location: Carnot
Soriba Naby Camara,
Gamal Abdel Nasser University of Conakry, Guinea
Title: Hepatic Abscess: Retrospective and Multicentric Study of 124 Observations to the University Hospital of Conakry
14:15-14:40
Biography
Soriba Naby Camara has completed his master’s in Surgery from Union Hospital Tongji Medical College in year of 2012 and PhD in Pancreatic Surgery in Union Hospital, Huazhong University of Sciences and Technology in year of 2016. In 2004 he served as teacher in Medical College in Gamal Abdel Nasser University of Conakry, and Physician in the department of Visceral Surgery of the National Hospital of Donka Conakry, Guinea. He as published more than 18 papers in the reputed journals.
Abstract
Location: Carnot
14:40-15:05
Biography
Dr. Very Coulic born in Belgium (1936), and has done primary and secondary school in Belgium and medical formation in Brussels University, Medicine Faculty (2.5 years) then Moscow 1st Medicine Institute named by IM Sechenov. There Ph.D. and High School Agreation degrees in Surgery. Docent in 1971, professor for Human Anatomy in 1971. Assistant, scientific worker, and teacher successively in the 1st Medicine Institute, the Academic Laboratory of organ and tissue Transplantation, at the People Friendship University.
Abstract
Location: Carnot
M Martin
Saint Quentin, France Title:
Title: Further developments of the energetic feedback for automated treatment of the severe acute glucose metabolism disorder monitoring
15:05-15:30
Biography
Marc Martin was born on 02/09/1959 in Antwerp and Currently working as an Deputy chief medical services, CHU Brugmann, Brussels
Abstract
Background. Previous investigations have proved that the use of differential temperature evolution as “energetic” feedback for monitoring the insulin treatment of severe hyperglycaemia, was not worse and may be better than the classical schema, independently on the pathology leading to this glucose metabolism disorder. Nevertheless some cases of hypoglycaemia were still recorded.
The aim of the present work was to elaborate, and to test in experiments (and clinics?) a device which will be able to preview and correct the hypoglycaemia development.
Material and methods. For the device elaboration with digital thermic sensors for body deep and superficial temperature registration, Atmel AVR processor, TFT touch screen and injection pumps for insulin and glucose automated injection were used. The device was tested in observation and treatment regimens in 30 rats, 5 informed healthy volunteers and 10 informed patients. During the procedures body and room temperatures were registered by the device and usual thermometer, peripheral glycaemia was measured by strips (One Touch, Switzerland).
Results. In observation regimen, the device was able to detect temperature events predicting a hypoglycaemia in animals and glucose metabolism disorder in humans. In treatment regimen in rats with Streptozotocin induced diabetes, a quick normalization of glycaemia could be reached by insulin injection, as well as a correction of temperature fall by glucose injection.
Conclusion. These first results have shown that it is possible to automate the treatment of severe acute glucose metabolism disorders by both insulin and glucose injection based on the evolution of body temperatures as a feedback. Further investigations are still necessary to confirm the device possibilities, particularly for chronic glucose disorders.
Acknowledgements to Drs Ph Van Der Linden (Anaesthesiology), L Bruyninx (Digestive Surgery), J Devriendt (ICU) for supporting this study
Location: Carnot
Khaled Elshaar
King Fahd Central Hospital, Saudi Arabia
Title: Further developments of the energetic feedback for automated treatment of the severe acute glucose metabolism disorder monitoring
15:30-15:55
Biography
Khaled Elshaar, MBBCH, MS, MD, MRCSEng, Egyptian Consultant General and Colo-Rectal surgery with special interests in Laparoscopic and trauma Surgery, graduated in 1995 from the Faculty of Medicine, Alexandria University, Egypt. His Magister, MS, and Doctorate MD, were in the field of Colo-Rectal Surgery. Worked for few years in the Alexandria University Hospitals, Egypt, moved after that to Saudi Arabia where he is working as a Consultant Surgeon in King Fahd Central Hospital Jazan, since 2004 till date. He is a member of EAES and Egyptian society of colorectal surgery. Had published his researches in the field of GIT surgery, and currently, working on rare cases reports to be published.
Abstract
Location: Carnot
Triki Ismail
Hospital Centre Of Saint Quentin, France
Title: Position and controversy with beta-blockers in cirrhosis in 2018
16:15-16:40
Biography
Triki Ismail as a gastroenterologist and specialist in the management of IBD, has his hospital and liberal experience to treat Inflammatory bowel disease in all of these aspects, as he has done research work in this direction , he is also Member of several associations for patient.
Abstract
The efficacy of non-selective beta-blockers (NSBBs) has been well established for the primary and secondary prophylaxis of variceal hemorrhage. With the progressive increase of portal hypertension over time in cirrhotic patients, blood pressure gradually decreases and heart rate increases to ensure appropriate perfusion of organs (especially the kidney). The use of NSBBs in severe cirrhotic patients in unstable hemodynamic conditions (especially after a spontaneousbacterial peritonitis (SBP) or in the presence of refractory ascites) increases the risk of hepatorenal syndrome and death, by counteracting the compensatory increase in cardiac output. In patients with decompensated cirrhosis or experiencing a drop in blood pressure, NSBBs should be stopped either transiently or definitively, depending on the hemodynamic outcome. Several studies have reported a deleterious effect of NSBBs after a SBP or in patients with refractory ascites. However, these findings lack of robustness since most of themcome from observational studies yielding a selection bias that cannot be entirely controlled even though sophisticated statistical approaches were applied. A close monitoring of renal function, serum sodium and blood pressure could allow a more appropriate management of NSBBs in patients hemodynamically unstable.Hence, in patients with compensated cirrhosis, the dose of propranolol and nadolol may be progressively increased, and carvedilol, a NSBB with intrinsic a1-blockage (which increases the hypotensive effect), may be used cautiously at a maximum dose of 12.5 mg/day. In patients with refractory ascites or SBP, NSBBs should be discontinued or reduced when systolic blood pressure decreases below90 mmHg or serum creatinine increases over 133 mmol/L ; furthermore, the dose of propranolol and nadolol should never exceed 160 mg/day and 80 mg/day, respectively, and carvedilol should be avoided in this context
Location: Carnot
16:40-17:05
Biography